Form 4: Adagio Medical Holdings Director, Sandra A. Gardiner, Reports Stock Option Grant

Sentiment:

SEC Form 4 Filing


Sandra A. Gardiner, a director of Adagio Medical Holdings, Inc., reported the acquisition of non-qualified stock options for 90,000 shares on March 20, 2025.

Summary

  • Sandra A. Gardiner, a director at Adagio Medical Holdings, Inc. (ADGM), filed a Form 4 with the SEC.
  • The filing reports the grant of non-qualified stock options to Gardiner on March 20, 2025.
  • Gardiner received options for 90,000 shares of Adagio Medical Holdings common stock at an exercise price of $0.865 per share.
  • The options were granted under the company's 2024 Equity Incentive Plan and approved by the Compensation Committee.
  • The options vest monthly over a three-year period, starting July 31, 2024, with 1/36th of the shares vesting each month of continuous service.
  • The options expire on July 31, 2034.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock options is a standard practice and generally viewed as a positive sign of aligning management interests with shareholders.

Positives

  • The stock option grant aligns the director's interests with those of the shareholders, incentivizing her to work towards increasing the company's value.
  • The vesting schedule encourages long-term commitment from the director.

Industry Context

Stock option grants are a common practice in the medical device industry to attract and retain talent, aligning their interests with the company's long-term success.

Comparison to Industry Standards

  • Stock option grants are a standard component of executive compensation packages in the medical device industry.
  • Companies like Medtronic, Boston Scientific, and Abbott also utilize stock options to incentivize their directors and key employees.
  • The vesting schedule and exercise price are typical for similar grants in the industry.

Stakeholder Impact

  • Shareholders may view the stock option grant positively as it aligns the director's interests with the company's performance.
  • Employees may see it as a positive sign of the company's commitment to its leadership.

Key Dates

DateDescription
07/31/2024Vesting commencement date for the stock options.
03/20/2025Date of the stock option grant.
03/21/2025Date of the Form 4 filing.
07/31/2034Expiration date of the stock options.

Keywords

Form 4, stock options, Adagio Medical Holdings, ADGM, Sandra A. Gardiner, director, equity incentive plan, beneficial ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.